Navigation Links
Discovery Sheds Light on Huntington's Disease
Date:6/4/2009

Researchers identify protein that could lead to treatment or prevention

THURSDAY, June 4 (HealthDay News) -- Scientists have pinpointed a protein that plays a key role in cell death in Huntingdon's disease, a degenerative disorder that leads to uncontrolled movements and loss of intellectual functioning.

The discovery raises hope that drugs could be developed to slow or halt the disease, according to a study in the June 5 issue of Science.

In Huntington's disease, cells in the corpus striatum, the area of the brain that controls movement, gradually die off.

Previous research has shown that people with Huntington's have a genetic defect that produces a mutant version of the protein "huntingtin," which accumulates in cells throughout the body.

But for reasons scientists didn't understand, the protein only kills cells in the corpus striatum. The protein causes little damage to tissues elsewhere.

In the new study, researchers discovered that a tiny protein called "rhes" -- found only in the corpus striatum -- interacts with the mutant huntingtin proteins, causing cell death.

The findings explain the pattern of brain damage in Huntington's disease and suggest strategies for developing new drug therapies, researchers at Johns Hopkins University said.

"It's always been a mystery why, if the protein made by the HD (Huntington's disease) gene is seen in all cells of the body, only the brain, and only a particular part of the brain, the corpus striatum, deteriorates," said Dr. Solomon H. Snyder, a professor of neuroscience at Johns Hopkins. "By finding the basic culprit, the potential is there to develop drugs that target it and either prevent symptoms or slow them down."

Huntington's is a familial disease, passed from parent to child through a gene mutation. A child of someone with Huntington's has a 50-50 chance of inheriting the gene, according to the National Institute of Neurological Disorders and Stroke.

Because the damage from the faulty gene is limited to the corpus striatum, researchers went searching for proteins that interacted specifically and exclusively with the huntingtin protein in that part of the brain.

Rhes is found almost exclusively in the corpus striatum, according to the study.

Using human and mouse cells, researchers found that rhes interacted with both healthy and mutant versions of huntingtin protein, but that it bound much more strongly to mutant huntingtin, also known as mHtt.

"Touching or binding is one matter, but death is altogether another," Snyder said.

Further tests using human embryonic cells and brain cells taken from mice showed that when both mHtt and rhes were present in the same cells, half the cells died within 48 hours. Rhes or mHtt alone did not cause cell death.

"Here's the rhes protein, we've known about it for years, nobody ever really knew what it did in the brain or anywhere else," Snyder said. "And it turns out it looks like the key to Huntington's disease."

Researchers also did a set of tests to learn more about the role of rhes. Previous research has shown that the abnormal huntingtin proteins form clumps in cells throughout the body and brain, but that there are fewer of the clumps in the corpus striatum.

"This has led to much controversy: Are the clumps toxic, or is it the lack of clumps that's toxic to these brain cells?" said Srinivasa Subramaniam, a postdoctoral fellow at Johns Hopkins.

Experiments showed that adding rhes to cells with abnormal huntingtin led to fewer clumps, but the cells died.

Researchers said that the unclumping of mutant huntingtin proteins by rhes might cause the cell death.

"Since rhes is highly found in the corpus striatum, clumping somehow protects cells in other tissues of the body from dying," Subramaniam said.

The team is currently testing to see if removing rhes from mice with Huntington's disease can slow or stop brain cells from dying.

"Now that we've uncovered the role of rhes, it's possible that drugs can be designed that specifically target rhes to treat or even prevent the disease," Snyder said.

More information

The National Institute of Neurological Disorders and Stroke.



-- Jennifer Thomas



SOURCE: Johns Hopkins University, news release, June 4, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Discovery of sugar sensor in intestine could benefit diabetes
2. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
3. Stem cell research produces a key discovery for Fragile X Syndrome
4. Welch Foundation gives $1.6 million for drug discovery research
5. New discovery leaves blood-doping athletes scratching their heads
6. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
7. New discovery leaves blood-doping athletes scratching their heads
8. Discovery of widespread tumor growth gene holds promise for effective anti-cancer treatment
9. Discovery supports theory of Alzheimers disease as form of diabetes
10. Discovery Health CME Explores the Benefits and Risks of Aspirin in Aspirin Therapy: Maximizing the Benefits
11. New discovery may improve treatment of one of the worlds leading causes of blindness
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Discovery Sheds Light on Huntington's Disease 
(Date:3/28/2017)... ... ... Usually, the impending arrival of warmer weather means the gleeful banishment of ... chin, this means more anxiety than elation. The cosmetic dermatology experts at Cosmetic Laser ... chin is undesirable,” Dr. Goldman said, “but it seems doubly so when the fat ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, ... ensuring high-quality results and maintaining GMP and USP compliance. In a new webinar ... with GMP requirements " these requirements are explained. The challenge is to ...
(Date:3/28/2017)... ... March 28, 2017 , ... Qualidigm , the mission-driven ... to a new, more expansive office space in order to accommodate its growing ... distressed office building in Wethersfield, Conn. located at 936 Silas Deane Highway and ...
(Date:3/28/2017)... ... 2017 , ... With less than 10,000 dermatologists in the United States and ... limited while the desire to conquer breakouts and eliminate skincare stress is widespread. ... online, today released its inaugural survey on the State of Acne in America. ...
(Date:3/28/2017)... ... March 28, 2017 , ... In its ongoing ... website has recently developed and published an informational resource that addresses frequently asked ... on common inquiries the site’s team of third party administrator (TPA) contributors regularly ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  Designers of primary cell ... solution size by 50% and extend battery life with ... management integrated circuit (PMIC) from Maxim Integrated Products, Inc. ... a low input voltage of just 0.7V for new ... Silver Oxide, as well as the more common Alkaline ...
(Date:3/29/2017)... KALAMAZOO, Michigan , USA, March 29, 2017 /PRNewswire/ ... a Company that Cares by People magazine, in partnership ... out of 50 companies on the list. This list ... employees that have succeeded in business while also demonstrating ... and the environment.  To determine the ...
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ - Medicure Inc. ... release financial results for the year ended December ... 26, 2017. The results are being released later ... financial statements will include the operations and balances ... 1, 2016.  This release and filing date meets ...
Breaking Medicine Technology: